News - Array BioPharma


Current filters:

Array BioPharma

Popular Filters

Shares jump as Array BioPharma reports positive results for asthma drug


US biotech firm Array BioPharma (Nasdaq: ARRY) saw its shares jump as it announced that its drug candidate…

Array BioPharmaBiotechnologyNorth AmericaResearchRespiratory and Pulmonary

Start-up Loxo Oncology in deal with Array BioPharma


Loxo Oncology, a biopharmaceutical company established and funded by Aisling Capital in May this year,…

Array BioPharmaBiotechnologyLicensingLoxo OncologyOncology

Oncothyreon and Array collaborate on anti-HER2 compound ARRY-380


US biotech firms Oncothyreon (Nasdaq: ONTY) and Array BioPharma (Nasdaq: ARRY) plan to collaborate on…

Array BioPharmaARRY-380BiotechnologyLicensingOncologyOncothyreonPharmaceuticalResearch

Selumetinib is first drug to help patients with recurrent low-grade ovarian cancer


In the first-targeted therapy clinical trial for low-grade serous ovarian cancer, eight of 52 (15%) patients…

Array BioPharmaBiotechnologyOncologyResearchselumetinib

First success of selumetinib, a targeted therapy in most common NSCLC


A new study by an international team of investigators led by Dana-Farber Cancer Institute scientists…

Array BioPharmaAstraZenecaOncologyPharmaceuticalResearchselumetinib

Array BioPharma presents encouraging Ph II selumetinib results in ovarian cancer


Encouraging Phase II trial with selumetinib, a small-molecule MEK inhibitor developed by USA-based Array…

Array BioPharmaAstraZenecaOncologyPharmaceuticalResearchselumetinib

Back to top